Please ensure Javascript is enabled for purposes of website accessibility

Why Tesla, Marathon Oil, and Intercept Pharmaceuticals Jumped Today

By Dan Caplinger – Apr 5, 2018 at 4:32PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out why these stocks helped lead the market higher.

The stock market did well on Thursday, with triple-digit gains for the Dow Jones Industrial Average and solid advances for broader benchmarks as well. Investors largely shrugged off concerns about trade disputes and macroeconomic challenges, expecting that the March report on the U.S. employment picture will likely show signs of continued growth that should point to an ongoing expansion for the economy. Some good showings from individual stocks also helped bolster market sentiment. Tesla (TSLA -4.59%), Marathon Oil (MRO -10.94%), and Intercept Pharmaceuticals (ICPT 0.00%) were among the best performers on the day. Here's why they did so well.

Tesla accelerates higher

Shares of Tesla jumped another 6.5%, bringing its gains over the past three days to more than 20%. The stock has bounced back sharply from recent lows because of good fundamental news from the electric car manufacturer, including signs of rising production rates that should keep the company from needing to raise more capital during the rest of 2018. Share prices had plunged after a poorly timed April Fools' joke from CEO Elon Musk raised bankruptcy fears, but bullish investors hope that a run rate of 2,000 Model 3 vehicles per week will only increase in the future. If that happens, then Tesla will finally start to gain recognition as being a viable long-term player in the massive auto industry.

Dark-colored Tesla car on a road with hills and foggy landscape behind.

Image source: Tesla.

Marathon looks more energetic

Marathon Oil stock added 6% on a good day for the energy sector. Oil prices themselves didn't show huge gains, with a rise of just $0.20 to bring the price above $63.50 per barrel. Yet after lagging behind the crude market for some time, oil stocks bounced back, with a sector ETF covering the energy space seeing gains of more than 2%. Marathon has been in the right place at the right time, building up exposure to lucrative shale plays in the U.S. market. That strategy has worked well, and if prices can keep rising, then Marathon looks well-positioned to see profits keep growing over the long run.

Intercept raises capital

Finally, shares of Intercept Pharmaceuticals rose 10%. The biopharmaceutical company said that it had successfully priced its secondary offering of common stock, raising the size of the offering to about 2.34 million shares and selling it at a price of $64 per share. Intercept also said that at the same time as the public offering, it had agreed to sell another 1.56 million shares to major institutional shareholders in a private placement for the same price. All told, the offering should raise $250 million for Intercept, and that should give the biotech company plenty of capital to fund its research and development efforts as well as its commercialization of its existing drug pipeline. That should make those who see Intercept as being cheap even more excited about the stock going forward.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Tesla. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tesla, Inc. Stock Quote
Tesla, Inc.
TSLA
$275.33 (-4.59%) $-13.26
Marathon Oil Corporation Stock Quote
Marathon Oil Corporation
MRO
$21.90 (-10.94%) $-2.69
Intercept Pharmaceuticals Stock Quote
Intercept Pharmaceuticals
ICPT
$15.24 (0.00%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.